108 related articles for article (PubMed ID: 30605956)
41. Combined therapy of enalapril and losartan attenuates histologic progression in immunoglobulin A nephropathy.
Tanaka H; Suzuki K; Nakahata T; Tsugawa K; Konno Y; Tsuruga K; Ito E; Waga S
Pediatr Int; 2004 Oct; 46(5):576-9. PubMed ID: 15491387
[TBL] [Abstract][Full Text] [Related]
42. Effects of rapamycin on angiomyolipomas in patients with tuberous sclerosis.
Cabrera López C; Martí T; Catalá V; Torres F; Mateu S; Ballarín Castán J; Torra Balcells R
Nefrologia; 2011; 31(3):292-8. PubMed ID: 21629335
[TBL] [Abstract][Full Text] [Related]
43. Efficacy of sirolimus in treating tuberous sclerosis and lymphangioleiomyomatosis.
Paul E; Thiele E
N Engl J Med; 2008 Jan; 358(2):190-2. PubMed ID: 18184966
[No Abstract] [Full Text] [Related]
44. Use of oestrogen-containing medication is not associated with renal angiomyolipoma in tuberous sclerosis: findings from a survey.
Sauter M; Sigl J; Schotten KJ; Kreuzer L; Günthner-Biller M; Fischereder M
Int Urol Nephrol; 2015 Apr; 47(4):707-8. PubMed ID: 25737072
[No Abstract] [Full Text] [Related]
45. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function.
Moriyama T; Honda K; Nitta K; Yumura W; Nihei H
Clin Exp Nephrol; 2004 Sep; 8(3):237-42. PubMed ID: 15480901
[TBL] [Abstract][Full Text] [Related]
46. Differentiating the mTOR inhibitors everolimus and sirolimus in the treatment of tuberous sclerosis complex.
MacKeigan JP; Krueger DA
Neuro Oncol; 2015 Dec; 17(12):1550-9. PubMed ID: 26289591
[TBL] [Abstract][Full Text] [Related]
47. [Angiomyolipoma--its role in prenatal diagnosis of tuberous sclerosis].
Vrtĕl R; Vodicka R; Santavá A; Santavý J; Krejciríková E
Cas Lek Cesk; 2004; 143(3):195-7. PubMed ID: 15134041
[TBL] [Abstract][Full Text] [Related]
48. Acthar gel in the treatment of nephrotic syndrome: a multicenter retrospective case series.
Madan A; Mijovic-Das S; Stankovic A; Teehan G; Milward AS; Khastgir A
BMC Nephrol; 2016 Mar; 17():37. PubMed ID: 27036111
[TBL] [Abstract][Full Text] [Related]
49. Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children.
Kang Z; Li Z; Duan C; Wu T; Xun M; Ding Y; Zhang Y; Zhang L; Yin Y
Pediatr Nephrol; 2015 Jul; 30(7):1121-9. PubMed ID: 25773534
[TBL] [Abstract][Full Text] [Related]
50. Bilateral renal angiomyolipomatosis in tuberous sclerosis presenting with chronic renal failure: case report and review of the literature.
Kalra OP; Verma PP; Kochhar S; Jha V; Sakhuja V
Nephron; 1994; 68(2):256-8. PubMed ID: 7830866
[TBL] [Abstract][Full Text] [Related]
51. Use of sirolimus in patients with primary steroid-resistant nephrotic syndrome.
Liern M; De Reyes V; Fayad A; Vallejo G
Nefrologia; 2012 May; 32(3):321-8. PubMed ID: 22508141
[TBL] [Abstract][Full Text] [Related]
52. Role of mTOR inhibition in the treatment of patients with renal angiomyolipomas.
Coombs EJ
J Am Assoc Nurse Pract; 2013 Nov; 25(11):588-96. PubMed ID: 24170533
[TBL] [Abstract][Full Text] [Related]
53. Nephrotic syndrome and rapid renal failure in autosomal dominant polycystic kidney disease.
Murphy G; Tzamaloukas AH; Listrom MB; Gibel LJ; Smith SM; Gardner KD
Am J Nephrol; 1990; 10(1):69-72. PubMed ID: 2343882
[TBL] [Abstract][Full Text] [Related]
54. Tuberous sclerosis with bilateral renal angiomyolipoma.
Bansal C; Lakshmaiah V; Raavesha A; Waadhawan P; Priyanka MK
J Assoc Physicians India; 2013 Jun; 61(6):420-3. PubMed ID: 24640214
[TBL] [Abstract][Full Text] [Related]
55. PKD1/TSC2 contiguous gene deletion syndrome.
Sundaram M; Kookana A; Duncan H; Mathew R
Nephrology (Carlton); 2017 Aug; 22(8):656-657. PubMed ID: 28685940
[No Abstract] [Full Text] [Related]
56. Congenital Lymphatic Malformation and Aortic Aneurysm in a Patient with TSC2 Mutation.
Wiemer-Kruel A; Mayer H; Ewert P; Martinoff S; Eckstein HH; Kriebel T; Bissler J; Franz D; Bast T
Neuropediatrics; 2020 Feb; 51(1):57-61. PubMed ID: 31505689
[TBL] [Abstract][Full Text] [Related]
57. Cutaneous Manifestations of Tuberous Sclerosis.
Bakić M; Ratković M; Gledović B; Vujović B; Radunović D; Babić V; Prelević V
Acta Dermatovenerol Croat; 2018 Apr; 26(1):73-74. PubMed ID: 29782307
[TBL] [Abstract][Full Text] [Related]
58. [HUGE RENAL ANGIOMYOLIPOMA (AML) IN TUBEROUS SCLEROSIS COMPLEX (TSC) WHICH IS CONTROLED BY EVEROLIMUS: A CASE REPORT].
Kanbara T; Sakaeda K; Kusaka N; Akebi N
Nihon Hinyokika Gakkai Zasshi; 2016; 107(1):54-58. PubMed ID: 28132993
[TBL] [Abstract][Full Text] [Related]
59. Tacrolimus improves the proteinuria remission in patients with refractory IgA nephropathy.
Zhang Q; Shi SF; Zhu L; Lv JC; Liu LJ; Chen YQ; Zhang H; Wang HY
Am J Nephrol; 2012; 35(4):312-20. PubMed ID: 22456060
[TBL] [Abstract][Full Text] [Related]
60. Possible prevention of tuberous sclerosis complex lesions.
Kotulska K; Borkowska J; Jozwiak S
Pediatrics; 2013 Jul; 132(1):e239-42. PubMed ID: 23733802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
